| Literature DB >> 31973015 |
Anna W Waller1, Juan E Andrade1,2, Luis A Mejia1.
Abstract
Iron fortification of staple foods is a common practice around the world to reduce the prevalence of iron-deficiency anemia. More recently, fortified condiments, including salts, sauces, and powders, have been tested in various efficacy trials. However, there is limited information on how nutritional, environmental, and experimental factors affect their efficacy and effectiveness. The purpose of the present work was to systematically review performance factors affecting the efficacy of condiment fortification trials. Three databases were searched using a standardized keyword search and included based on four-point inclusion criteria. Studies were evaluated against a quality assessment tool and effect sizes were calculated. Studies were ranked as low or high performing, based on whether or not they significantly improved iron-deficiency outcomes (hemoglobin, anemia prevalence, and ferritin levels). Of the 955 retrieved studies, 23 were included-of which, nine performed poorly, eight performed highly, and six were classified as neither because they did not meet the criteria of assessing the three iron outcomes. Results showed that unsuccessful trials did not consider environmental factors such as parasitic infections, nutritional factors such as micronutrient deficiencies other than iron, consumer acceptability of the product or experimental factors such as monitoring and adherence to the trials. Two common performing factors identified among those studies performing highly vs. those that did not were the control of sensory changes and monitoring of consumption compliance (i.e., dose delivery). The present work can be used as decision-making support for nutrition policy makers when determining the appropriate implementation of condiment fortification programs.Entities:
Keywords: condiments; fortification; iron-deficiency anemia
Year: 2020 PMID: 31973015 PMCID: PMC7070935 DOI: 10.3390/nu12020275
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1PRISMA study selection flow chart.
Data extraction for systematically selected 23 studies.
| Study/Objective/Country/Duration and Experimental Design/Subjects | Condiment/ | Iron Intervention Outcomes (Hemoglobin, Anemia Prevalence, and Ferritin) | Selected Performance Indicators | ||||
|---|---|---|---|---|---|---|---|
| Education/Behavior Change Component | Parasitic Treatment | Sensory/Acceptability Testing | Monitoring Compliance/Adherence | Other Micronutrients Associated with Anemia | |||
| Andersson et al., 2008 [ | DFS | Hb (+0.6 * and +0.8 * g/dL, FePP and FF) | At each salt distribution, families were instructed that the new salt should be used for all cooking and food preparation. Health effects were explained to noncompliant families. | Albendazole treatment at 1 mo and 8 mo | Sensory panel ( | Salt container was weighed on four consecutive mornings ( | Vitamin A supplements (200,000 IU) distributed at 1 mo |
| Asibey-Berko et al., 2007 [ | DFS | No Hb post-treatment data | NA | NA | 2.7% of the women in the DFS group reported darkening of fried plantains with DFS | Weekly household visits to monitor salt usage, encourage compliance, and check health status (diarrhea, pregnancy, malaria, constipation). | NA |
| Bathla et al., 2016 [ | DFS | Hb (+0.6 * g/dL) | NA | NA | NA | Supervision of a researcher during mid-day meal. | NA |
| Haas et al., 2014 [ | DFS | Hb (+0.24 * g/dL) | NA | 200 mg of albendazole at −4 wk and at study midpoint | Stability, organoleptic, and acceptability testing of the DFS showed some discoloration and black specks, but the salt was still considered acceptable for consumption by all of the participants | Salt consumption was monitored at midpoint and endline by weighing salt bags, salt consumed at major meals, and dietary recalls. | Folate deficiency (−13% *) |
| Nair et al., 2014 [ | DFS | Hb (−0.15 g/dL) | Nutrition Health Education (NHE) specifically pertaining to the use and storage of DFS, iron-rich foods, consequences of deficiency. | NA | NA | Compliance monitoring NA | NA |
| Rajagopalan et al., 2000 [ | DFS | Hb (+0.85 * and 1.55 * g/dL, men and women) | Education on DFS nutritional benefits, cooking demonstrations. | Dewormed half the population at baseline | Through cooking demonstrations, they observed that the fortified salt did not change the color, taste, or appearance of the food | Periodic surprise visits to the houses of the workers and collected salt samples from their kitchens for analysis. These checks proved that the population was using only Nutrisalt. | NA |
| Reddy et al., 2014 [ | DFS | Hb (+0.6 * g/dL and 0.21 * g/dL, deworming and not) | All the groups were also provided nutrition and health education regarding the need and importance of iodine and iron nutrition in children. | Albendazole (400 mg) given twice | NA | NA | NA |
| Reddy et al., 2016 [ | DFS | Hb (+0.42 * g/dL) | NA | NA | NA | Nutrient intake was recorded using 24 h dietary recall information. | All pregnant women were on iron, folic acid, and calcium supplements during 2nd and 3rd trimester |
| Vinodkumar et al., 2007 [ | DFS | Hb (+1.98 * g/dL) | NA | Dewormed at baseline, 6 mo, and 12 mo | No complaints regarding taste. People noted that the amount of salt to be added to food was less, and that food turned slightly sour when kept for more than 6 h. After use for 1 y, 98%–100% of households rated the taste and color of DFS as acceptable. | NA | NA |
| Wegmueller et al., 2006 [ | DFS | Hb (0 g/dL) | In a village meeting at the beginning of the study and at each of the monthly salt distribution, it was emphasized that the salt should be used for all cooking, food preparation, and at the table. | At the baseline screening and again at 4 mo, all children received an oral dose of 400 mg albendazole | Triangle test by 18–21 untrained local adults were not able to detect differences in color, odor, or taste in either traditional staples (rice, cassava, yam, plantain) or sauces (tomato, eggplant, okra, palm nut) | Remaining salt at the end of the month was weighed and the amount of salt consumed per day per person during the period since the last distribution calculated. | Median vitamin A intake was at the EAR for children 2–5 y and above the EAR for children 6–15 y, women, and men, due to high consumption of red palm oil and refined palm oil fortified with retinyl palmitate. 7% of children had vitamin A deficiency at baseline |
| Wenger et al., 2017 [ | DFS | Hb (+0.1 * g/dL) | NA | 200 mg albendazole was administered to all eligible participants 4 wk before and 4 mo after the initial baseline blood collection | It was considered acceptable by participants in a previous study | NA | Folate deficiency (−22% *) |
| Zimmermann et al., 2003 [ | DFS | Hb (+1.4 * g/dL) | At each monthly salt distribution, all salt used for cooking and food preparation was emphasized. | NA | Baseline acceptability interviews indicated nearly unanimous acceptance. At 8 mo, 14% of households rated the color unacceptable in the damp season. 17% reported that the salt changed the color of foods. In a triangle test, there was no significant, detectable difference in color, odor, or taste | NA | NA |
| Zimmermann et al., 2004 [ | DFS | Hb (+1.5 * g/dL) | NA | NA | Triangle test showed no significant difference in color, odor, or taste between the salts in any of the traditional foods | NA | NA |
| Kumar et al., 2007 [ | Multiple micronutrient fortified salt (microencapsulated vitamin A, B1, B2, B6, B12, folic acid, niacin, calcium pantothenate, and iodine) | Hb (+0.65 * g/dL) | NA | 400 mg albendazole at baseline, after 6 mo and 1 y of intervention (end of study) | The fortified salt did not change the color or taste of any food preparation | The continuous use of the fortified salt in all the meals prepared every day was monitored. | Salt contained 5 μg folic acid/g salt, 400 μg vitamin B12/kg salt, and 300 IU vitamin A/g salt. Serum vitamin A significantly increased by 4.9 μg/dL |
| Kumar et al., 2014 [ | Multiple micronutrient fortified salt (iron, iodine, vitamin A, vitamin B12, and folic acid) | Hb (+0.5 g/dL) | Prior to the start of the study, a list of locally available foods that are rich in micronutrients and recipes for was communicated. Then, every month a specific topic was chosen, and in-depth education was given on that topic. | Children in all three arms of the study were given a tablet of albendazole (400 mg) at baseline and post-intervention after 8 mo | NA | Health workers visited the homes once a month to collect leftover salt. | Salt contained 1 μg folic acid/g salt, 0.1 μg vitamin B12/g salt, and 300 IU vitamin A/g salt. Vitamin A deficiency prevalence reduced by 23.5% |
| Vinodkumar et al., 2009 [ | Multiple micronutrient fortified salt (microencapsulated vitamins A, B1, B2, B6, B12, folic acid, niacin, calcium pantothenate, and iodine) | Hb (+0.55 * g/dL) | NA | Albendazole 400 mg at baseline, after 6 mo and after 1 y of intervention | NA | Continuous use in daily cooking was monitored. | Salt contained 5 μg folic acid/g salt, 0.4 μg vitamin B12/g salt, and 300 IU vitamin A/g salt. There was a 5.6 μg/dL increase in serum vitamin A. |
| Vinodkumar et al., 2009 [ | Multiple micronutrient fortified salt (vitamins A, B1, B2, B6, B12, folic acid, niacin, iron, iodine, and zinc) | Hb (+0.67 * g/dL) | NA | Albendazole (400 mg) at baseline, 4 mo, and post-trial at 9 mo | The cooking staff confirmed that the fortified salt did not change the color or taste of any food | Weighed salt leftover from the previous month to verify compliance. | Salt contained 10 μg folic acid/g salt, 0.4 mcg vitamin B12/g salt, and 300 IU vitamin A/g salt. There was a significant 4.7 μg/dL increase in serum vitamin A and 10,129 pg/mL increase in serum B12. Serum folic acid significantly decreased by −6.28 ng/mL. |
| Zimmermann et al., 2004 [ | Triple fortified salt (iron, vitamin A, iodine) | Hb (+1.5 * g/dL) | NA | NA | Triangle test showed no significant difference in color, odor, or taste (or all three) between the fortified salts in any of the traditional foods. However, 32% noted a color change in one or more foods when the salt was added. This did not affect the overall acceptability | NA | Salt contained 60 μg vitamin A/g salt. Vitamin A deficiency decreased by 8%. |
| Winichagoon et al., 2006 [ | Seasoning powder (zinc, iron, vitamin A, and iodine) | Hb (+0.31 g/dL) | NA | NA | NA | Teachers recorded whether the child ate “all,” “more than half,” “half,” “less than half,” or “none” of the school lunch. | The seasoning packet contained 270 μg of vitamin A. Fortification had no effect on serum retinol. |
| Longfils et al., 2008 [ | Fish sauce | Hb (+0.29 * g/dL and +0.31 * g/dL, FeSO4+ citrate and NaFeEDTA) | NA | 500 mg Mebendazole at the beginning, in the middle, and at the end of the study in addition to doses provided by the National Health Program | The taste of the school meals, corresponding to an average Cambodian fare, remained unaffected after the addition of either variety | Field workers fully supervised the ingestion of the meals. Food that was not consumed was re-weighed and recorded. | NA |
| Van Thuy et al., 2005 [ | Fish sauce | Hb (+0.54 * g/dL) | NA | NA | The fortified fish sauce was well accepted by the target population over an 18 mo period | Compliance monitoring NA | <8.0% of the women had vitamin A deficiency. |
| Chen et al., 2005 [ | Soy sauce | Hb | NA | NA | A survey of the organoleptic qualities and acceptance of the fortified/unfortified soy sauce was conducted in 187 households. Both products were considered to be of high quality and no complaints of adverse effects. The two were reported to taste the same | Food frequency questionnaires at baseline, 6, 12, and 18 mo. | There were no significant differences in plasma retinol levels between the fortified and control groups. There may be a high prevalence of subclinical vitamin A deficiency in these villages. Folate and B12 deficiencies should be considered in future studies. |
| Huo et al., 2002 [ | Soy sauce | Hb (+2.03 * and +2.39 * g/dL, low and high Fe levels) | NA | NA | NA | The soup was consumed under complete supervision from the teachers. At the same time, detailed information on the soy sauce consumption of each subject was recorded on a consumption sheet. | NA |
Notes: DFS—double-fortified salt; FePP—ferric pyrophosphate; FF—ferrous fumarate; EFF—encapsulated FF; FS—ferrous sulfate; Hb—hemoglobin; ID—iron deficiency; mo—month; NA—data or information not available or unknown; NP—non-pregnant; NL—non-lactating; RCT—randomized control trial; wk—week; WRA—women of reproductive age; y—year. * Indicates statistically significant outcome.
Studies with statistically significant changes in markers of anemia and iron status.
| Outcome | Children (16 Studies) 1 | Women (Eight Studies) 2 | Whole Population (One Study) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| YES | NO | NA | YES | NO | NA | YES | NO | NA | |
| Increased hemoglobin | 13 | 3 | 0 | 6 | 1 | 1 | 1 | 0 | 0 |
| Decreased anemia | 10 | 2 | 4 | 4 | 3 | 1 | 0 | 0 | 1 |
| Increased Ferritin | 9 | 2 * | 5 | 4 | 0 | 4 | 0 | 0 | 1 |
NA: not assessed. 1 Children studies include those exclusively assessing children, Chen [42] (disaggregates data based on gender and age), and Asibey-Berko [22] (assesses both women and children). 2 Women studies include those exclusively assessing women, Chen [42] (disaggregates data based on gender and age), and Asibey-Berko [22] (assesses both women and children). * Overall interaction was significant (due to negative changes in the control group) [37].
Low-performing studies of the efficacy of iron fortification of condiments. Impact on hemoglobin, anemia, and iron status.
| Category from | Study/Objective/Country/Duration and Experimental Design/Subjects | Condiment/ | Iron Intervention Outcomes (Hemoglobin, Anemia Prevalence, and Ferritin) | Suggested Possible Causes (Low-Performing Factors) |
|---|---|---|---|---|
| Did not increase hemoglobin significantly (children) | Kumar et al., 2014 [ | Multiple micronutrient fortified salt (iron, iodine, vitamin A, vitamin B12, and folic acid) | Hb (+0.5 g/dL, NS) | Insignificant hemoglobin increase was not addressed by authors |
| Did not increase hemoglobin significantly (children) | Wegmueller et al., 2006 [ | DFS | No change in Hb (0 g/dL) | High prevalence of malaria (55%) and multiple micronutrient deficiencies (B2 deficiency 66%). |
| Did not increase hemoglobin significantly (children) | Winichagoon et al., 2006 [ | Seasoning powder (zinc, iron, vitamin A, and iodine) | No significant change in Hb (+0.31 g/dL, NS) | Insufficient content (5 mg/serving) and form of iron used in the intervention (Reduced elemental Fe) |
| Did not increase hemoglobin significantly (women) | Nair et al., 2014 [ | DFS | Hb change before and after intervention: −0.15 g/dL (NS) | Not enough Fe intake to meet pregnancy needs during only 2 mo of |
| Did not decrease anemia significantly (children) | Reddy et al., 2014 [ | DFS | Hb (+0.6 * g/dL and 0.21 * g/dL, deworming and not) | Absence of deworming |
| Did not decrease anemia significantly (women) | Asibey-Berko et al., 2007 [ | DFS/ | No Hb post-treatment data | Significant increase of anemia in the control group. Uneven baseline prevalence of anemia. |
| Did not decrease anemia significantly (women) | Haas et al., 2014 [ | DFS | Hb (+0.24 * g/dL) | High prevalence of folate and B12 deficiencies. High prevalence of elevated MCV (25%) |
| Did not decrease anemia significantly (women) | Reddy et al., 2016 [ | DFS | Hb (+0.42 * g/dL) | Significance of anemia not addressed by authors |
| Did not increase ferritin significantly (children) | Vinodkumar et al., 2009, Int. J Vit Nut Res [ | Multiple micronutrient fortified salt (vitamins A, B1, B2, B6, B12, folic acid, niacin, iron, iodine, and zinc) | Hb increased (+0.67 * g/dL) | Uneven prevalence of anemia and ferritin levels at baseline. |
Notes: DFS—double-fortified salt; FePP—ferric pyrophosphate; FF—ferrous fumarate; EFF—encapsulated FF; FS—ferrous sulfate; Hb—hemoglobin; ID—iron deficiency; mo—month; NA—data or information not available or unknown; NP—non-pregnant; NL—non-lactating; RCT—randomized control trial; wk—week; WRA—women of reproductive age; y—year. * Indicates statistically significant outcome.
Figure 2Effect sizes of studies included in this review. The effect size was bias-corrected using the Hedges estimation. When a similar study is included, more information in parentheses indicates the difference. Double-fortified salt (DFS), fish sauce, soy sauce, multiple micronutrient salt (MMS), fortification. Deworming (DW), ferrous fumarate (FF), and ferric pyrophosphate (FPP).
High-performing studies of the efficacy of iron fortification of condiments. Studies were selected because all iron indicators (hemoglobin, anemia prevalence, and ferritin) demonstrated a positive impact.
| Study/Objective/Country/ Duration and Experimental Design/Subjects | Condiment/Fe source/Concentration | Iron Intervention Outcomes (Hemoglobin, Anemia Prevalence, and Ferritin) | Reported Possible Causes of Success | Quality Assessment Score and Effect Size |
|---|---|---|---|---|
| Andersson 2008 [ | DFS | Hb (+0.6 * and +0.8 * g/dL, FePP and FF) | Reiteration of health effects and instructions at each salt distribution | Strong quality assessment |
| Wenger 2017 [ | DFS | Hb (+0.1 * g/dL) | Parasitic treatment | Strong quality assessment |
| Zimmermann 2003 [ | DFS | Hb (+1.4 * g/dL) | Assessed acceptability and sensory | Strong quality assessment |
| Zimmermann 2004 [ | DFS | Hb (+1.5 * g/dL) | Assessed acceptability and sensory | Strong quality assessment |
| Van Thuy 2005 [ | Fish sauce | Hb (+0.54 * g/dL) | Assessed acceptability | Strong quality assessment |
| Chen 2005 [ | Soy sauce | Hb | Assessed sensory and acceptability | Strong quality assessment |
| Kumar 2014 [ | Multiple micronutrient fortified salt (iron, iodine, vitamin A, vitamin B12, and folic acid) | Hb (+0.5 g/dL) | Education component | Strong quality assessment |
| Zimmermann 2004 [ | Triple fortified salt (iron, vitamin A, iodine) | Hb (+1.5 * g/dL) | Assessed sensory and acceptability | Strong quality assessment |
Notes: DFS—double-fortified salt; FePP—ferric pyrophosphate; FF—ferrous fumarate; EFF—encapsulated FF; FS—ferrous sulfate; Hb—hemoglobin; ID—iron deficiency; mo—month; NA—data or information not available or unknown; NP—non-pregnant; NL—non-lactating; RCT—randomized control trial; wk—week; WRA—women of reproductive age; y–year. * Indicates statistically significant outcome.